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he concept of the Three Rs—
reduction, refinement, and
replacement of animal use in
biomedical experimentation—stems
from a project launched in 1954 by 
a British organization, the Universi-
ties Federation for Animal Welfare
(UFAW). UFAW commissioned William
Russell and Rex Burch to analyze the
status of humane experimental tech-
niques involving animals. In 1959
these scientists published a book that
set out the principles of the Three Rs,
which came to be known as alterna-
tive methods. Initially, Russell and
Burch’s book was largely ignored, but
their ideas were gradually picked up
by the animal protection community
in the 1960s and early ’70s. In the
’80s, spurred by public pressure, the
alternatives approach was incorporat-
ed into national legislation through-
out the developed countries and
embraced by industry in Europe and
America. Government centers devot-
ed to the validation and regulatory
acceptance of alternative methods
were established during the ’90s. By
2000 the use of animals in research
had fallen by up to fifty percent from






Animals have been used as experi-
mental subjects in biomedical re-
search, testing, and education during
the last 150 to 200 years, but the
practice began to burgeon in nine-
teenth century Europe. Alarmed by
this increase, early critics of animal
research challenged it from several
perspectives. They argued variously
that animal research was cruel and
inhumane; unethical; and medically
unproductive, unnecessary, or even
misleading. Their criticism largely
proved unpersuasive (French 1975;
Turner 1980). Activism in the United
States over animal research waned
after World War I and remained at a
low level until after World War II,
when a new dimension in the animal
research controversy emerged.
Spurred in part by advances in
technological methods, animal pro-
tectionists began advocating for
alternatives to laboratory animal use,
not simply advocating against animal
use or otherwise criticizing the sta-
tus quo. These alternatives make up
the Three Rs: methods that could
replace or reduce laboratory animal
use in specific procedures or refine
such use so that animals experience
less suffering. Sympathetic scientists
joined in this more constructive
approach; indeed, scientists them-
selves were the ones who first formu-
lated the Three Rs concept. At the
dawn of the twenty-first century, this
approach is proving to be a powerful
force in decreasing the use and dis-
tress of animals in experimental biol-
ogy and medicine.




and Replacing the Use
of Laboratory Animals
An updated version of “Looking Back Thirty-three Years to Russell and Burch: 
The Development of the Concept of the Three Rs (Alternatives)” (Rowan 1994)
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Estimates of the numbers of re-
search animals used annually in the
United States and worldwide are high-
ly speculative. The last official esti-
mate for the United States was 17 to
22 million animals (U.S. Office of
Technology Assessment 1986), but
that study was conducted more than
fifteen years ago. There is some evi-
dence that this estimate was made
during a period of declining animal
use that began in the 1960s and
continued into the ’90s (Rowan et
al. 1995). Consequently, the current
figure could be lower. Worldwide
animal use was estimated to be
between 60 and 85 million animals
in the early 1990s (Rowan 1995),
but more conservative estimates of
rodent use suggest a total of 40 mil-
lion animals worldwide (D. Kawahara,






The British scientists William Russell
and Rex Burch formally launched the
Three Rs with their book The Princi-
ples of Humane Experimental Tech-
nique (Russell and Burch 1959). How-
ever, hints of Russell and Burch’s
ideas had appeared in earlier discus-
sions about the appropriate use of
animals in research. Marshall Hall, a
British experimental physiologist dur-
ing the first half of the nineteenth
century, proposed five principles for
animal experimentation that would
eliminate unnecessary and repetitive
procedures and minimize suffering
(Manuel 1987). Hall also recommend-
ed the use of phylogenetically “lower,”
less sentient, animals and praised the
findings of a colleague who demon-
strated that an animal that had just
been killed could be substituted for a
living one, thereby eliminating pain.
Fifty years after Hall set out his 
five principles, a short-lived research
foundation—the Leigh Brown Trust—
was established to promote and
encourage scientific research without
inflicting pain on experimental ani-
mals (French 1975). Although the
Trust commissioned several publica-
tions in the 1890s, it never succeeded
in developing a research program
that convinced a significant propor-
tion of the research community to
adopt its principles. From 1900 to
1950, those who opposed the use of
animals lost much of their political
influence and were relegated to the
fringes of political activity. As a
result, little attention was paid to the
ethical questions posed by the use of
animals in research.
After World War II, interest in the
animal research issue began to grow
again. In the United States, newly
formed animal protection groups
began to criticize animal research
practices. In England the Three Rs
concept of alternatives began to
emerge from the work of UFAW.
UFAW published a handbook on the
care and management of laboratory
animals (Worden 1947) that was well
received. This gave UFAW the confi-
dence to address the more con-
tentious topic of experimental tech-
niques involving animals (as distinct
from animal care). Accordingly, in
1954 Major Charles Hume (the
founder of UFAW and its director at
the time) established a committee to
initiate a systematic examination of
the progress of humane technique in
the laboratory. Hume served as the
committee’s secretary, but it is note-
worthy that the committee was
chaired by Peter Medawar, a well-
respected immunologist, and also
included among its members William
Lane-Petter, secretary of the Research
Defence Society, an organization
established to defend animal research.
The committee employed William
Russell (a zoologist) and Rex Burch (a
microbiologist) to carry out the pro-
ject (Hume 1962). 
The exact origin of the Three Rs
concept is not entirely clear (Russell
1995). In a 1959 talk, Hume indicat-
ed that Russell was the originator 
of the “Three Rs” concept (Hume
1962), while Russell (1995), in a ret-
rospective paper entitled “The Devel-
opment of the Three Rs Concept,”
credited Hume as our “inspiration and
guide throughout.” In that paper Rus-
sell recalled that the Three Rs concept
evolved sometime between the sum-
Table 1
Alternatives Chronology: 1876–1959
1876 Cruelty to Animals Act—the first law to specifically
regulate animal experimentation—is enacted in 
Great Britain.
1927 The LD50 Test is introduced to standardize the
potency of digitalis extract.
1938 The Federal Food, Drug, and Cosmetic Act is enacted,
marking the first time a U.S. government agency 
is given the power to regulate consumer products.
1944 Eye irritancy testing is standardized as the 
Draize Test.
1954 Universities Federation for Animal Welfare (UFAW)
establishes a committee to study humane techniques
used in laboratory animal experiments.
1957 UFAW holds a symposium, “Humane Techniques in
the Laboratory,” at which William Russell presents 
a paper, marking the first time the Three Rs of
replacement, reduction, and refinement are discussed 
in public.
1959 Russell and Burch’s study is published as The Principles
of Humane Experimental Technique, which develops 
the Three Rs approach at length.
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mer of 1955 and May 1957. The first
recorded mention of the Three Rs was
on May 7, 1957, at a meeting,
“Humane Technique in the Laborato-
ry,” organized by UFAW and chaired by
Medawar. Russell (1957) gave a pre-
sentation at this meeting in which he
described the Three Rs. A brief pro-
ceedings (Anonymous 1957) was pub-
lished later that year by the Laborato-
ry Animals Bureau of the Medical
Research Council. Many of the argu-
ments and ideas presented by Russell
and the other speakers later appeared
in The Principles of Humane Experi-
mental Technique (Russell and Burch
1959). See Table 1 for a chronology of
these and other early developments. 
It is noteworthy from an American
perspective that the U.S.-based Ani-
mal Welfare Institute (AWI) provided
financial support to Russell and
Burch’s project and that AWI’s Chris-
tine Stevens made frequent visits to




Although The Principles of Humane
Experimental Technique has now be-
come the classic text on alternatives, it
received little attention when it was
published in 1959 despite its promo-
tion by UFAW in England and the AWI
in the United States. There are several
examples of the lukewarm reaction to
the book within the scientific commu-
nity. In Nature, a leading international
science journal based in England,
Weatherall (1959) commented:
[It] is useful to have a résumé
of ways which have already been
adopted to make experimentation
as humane as possible…[but the
book] is not sufficiently informa-
tive to be used as guide either to
details of experimental design or
to the husbandry of experimental
animals. Perhaps its chief purpose
is to stimulate thought on both of
these topics, and it is to be hoped
it will succeed in doing so. 
The British journal Veterinary
Record (Anonymous 1959) comment-
ed that the book contained an impor-
tant message and hoped that it would
not be relegated “to the shelves mere-
ly for reference,” but found the phi-
losophy “somewhat difficult reading.”
The British medical journal The
Lancet (Anonymous 1960) also found
the book difficult going, noting that
“its purpose is admirable, and its mat-
ter unexceptionable,” but “it is not
easy reading.” It is not clear whether
the tepid reviews reflected a general
lack of interest in the topic or were a
reaction to the book’s arguments (a
contemporaneous Nature review of a
book that defended the use of ani-
mals [LaPage 1960] was, by contrast,
full of praise). 
LaPage’s (1960) defense of animal
research described the contributions
of animal research to medical ad-
vance and mentioned Russell and
Burch and the concept of the Three
Rs only once, in a final chapter. He
noted that distinguished scientists at
a UFAW meeting
discussed, among other things,
how the numbers of laboratory
animals used, and the numbers of
experiments done on them, could
be reduced, how their welfare
could be improved, how the tech-
niques used could be refined and
how far, as Russell and Burch
(1959) also discuss, animals could
be replaced, for certain kinds of
experiments at any rate.
After the initial book reviews and
aside from the occasional mention of
the idea of alternatives in the techni-
cal literature, the scientific commu-
nity largely ignored Russell and
Burch’s book for nearly two decades.
According to an analysis by Phillips
and Sechzer (1989), the term “alter-
natives” did not appear in the scien-
tific literature on the animal research
issue in the 1960s, aside from a 1966
paper alluding to the concept.
During the 1960s, the animal pro-
tection community occasionally heed-
ed Russell and Burch’s 1959 call for
alternatives (Table 2). In 1962 three
leading antivivisection societies in
the United Kingdom (the British
Union for the Abolition of Vivisection,
the National Antivivisection Society
[NAVS], and the Scottish Society for
the Prevention of Vivisection) estab-
Table 2
Alternatives Chronology: 1960–1969
1962 Lawson Tait Trust (UK) is established—the first
research fund to support the scientific development
of alternatives.
1963 The first edition of The Guide for the Care and Use of
Laboratory Animals, written by the National Academy
of Sciences, is published by the National Institutes 
of Health.
1965 Littlewood Committee Report (UK) concludes that
little would be gained by paying special attention 
to alternatives.
1967 United Action for Animals is formed in the 
United States and later campaigns specifically 
for replacement alternatives.
1969 The Fund for the Replacement of Animals in 
Medical Experiments (FRAME) is formed in the
United Kingdom to promote to the scientific 
community the idea of alternatives.
1969 Lord Dowding Fund (UK) is established to support
alternatives research.
Sir Peter Medawar correctly predicts the subsequent
worldwide decline in animal use.
lished the Lawson Tait Trust to
encourage and support researchers
who were not using any animals in
their research. In 1967 United Action
for Animals was established in the
United States to promote alterna-
tives, focusing on the principle of
replacement. It’s founder, Eleanor
Seiling, spent many hours in the New
York Public Library poring through
scientific journals looking for exam-
ples of unnecessary animal research
and of alternatives. However, she
appears to have been a lone voice in
the United States. By and large the
animal protection literature of the
1960s did not pay much attention to
the idea of alternatives.
Aside from these few examples of
individuals taking up Russell and
Burch’s challenge in the years imme-
diately following publication of their
book, their ideas did surface directly
or indirectly from time to time. In the
early 1960s, the British Home Office
set up a Committee of Inquiry into
the workings of the 1876 Cruelty to
Animals Act, chaired by Sir Sidney
Littlewood. The Littlewood Commit-
tee report (1965) addressed the
question of alternatives only briefly,
but the mention at least indicated
that the issue was beginning to be
raised in public discourse. The Com-
mittee reported that it had
repeatedly questioned scientific
witnesses about the existence of
alternative methods which would
avoid the use of living animals.
The replies have been unanimous
in assuring us that such methods
are actively sought and when
found are readily adopted…Dis-
coveries of adequate substitutes
for animal tests have, however, so
far been uncommon, and we have
not been encouraged to believe
that they are likely to be more fre-
quent in the future” (paragraph
71).
The Committee accepted these
arguments and concluded that the
demand for the use of animals in
biomedical research was likely to
increase in the coming years and that
the discovery of substitutes for ani-
mal tests was not likely to affect the
demand for animal experimentation.
In the United States in the early
1960s, pressure from animal protec-
tionists led to several congressional
hearings on bills to regulate animal
research. The printed record of the
1962 hearings is 375 pages long but
apparently contains only one refer-
ence to Russell and Burch and none
at all to alternatives (U.S. Congress
1962). The one reference to Russell
and Burch came in testimony by
Hume, still the director of UFAW, who
had been flown to the United States
to testify that the Cruelty to Animals
Act (1876) was well regarded by
British scientists. Also in 1962, The
Humane Society of the United States
(HSUS) published a booklet, Animals
in Research, that alluded to the con-
cept of reduction. The booklet report-
ed the results of an analysis commis-
sioned by The HSUS and carried out
by Westat Research Analysts of the
statistical approach used in published
research papers (Anonymous 1962).
The analysts concluded that the sta-
tistical design of the published stud-
ies was usually inadequate and that at
least 25 percent fewer animals could
have been used without altering the
validity of the results. 
Arguably the most significant devel-
opment on the alternatives front dur-
ing the 1960s was the establishment
in 1969 of the U.K.-based charitable
organization FRAME (Fund for the
Replacement of Animals in Medical
Experiments) to promote the concept
of alternatives among scientists.
Although small in size and influence
in its early years, FRAME has become
a powerful force for advancing alter-
native methods. Also in 1969 the
U.K.-based NAVS set up the Lord
Dowding Fund to support alternatives
research. Both FRAME and the Dowd-
ing Fund were relatively well received
by some popular science magazines
(both the New Scientist and World
Medicine praised the new, more scien-
tific approach represented by the two
organizations). Attitudes in the Unit-
ed States were more negative. A 1971
editorial in the Journal of the Ameri-
can Medical Association (Anonymous
1971) criticized FRAME in scathing
terms, commenting that FRAME
might be better named FRAUDS (Fund
for the Replacement of Animals Used
in the Discovery of Science).
By the close of the 1960s, Peter
Medawar, the British scientist who
had encouraged UFAW to undertake
the Russell and Burch project, had
won a Nobel Prize for his work in
immunology and had been knighted
by the British Crown. In a 1969 essay
published a few years later, Medawar
commented presciently on the
prospects for alternatives and a
decrease in animal use:
The use of animals in laboratories
to enlarge our understanding of
nature is part of a far wider
exploratory process, and one can-
not assay its value in isolation—as
if it were an activity which, if pro-
hibited, would deprive us only of
the material benefits that grow
directly out of its own use. Any
such prohibition of learning or
confinement of the understand-
ing would have widespread and
damaging consequences; but this
does not imply that we are forever-
more, and in increasing numbers,
to enlist animals in the scientific
service of man. I think that the use
of experimental animals on the
present scale is a temporary
episode in biological and medical
history, and that its peak will be
reached in ten years time, or per-
haps even sooner. In the mean-
time, we must grapple with the
paradox that nothing but re-
search on animals will provide us
with the knowledge that will
make it possible for us, one day,
to dispense with the use of them
altogether” (Medawar 1972,
emphasis added).





During the 1970s, the alternatives
approach became a key theme for the
animal protection movement, which
was growing in both size and political
clout (Rowan 1989). The HSUS estab-
lished a committee of experts on
alternatives in the early ’70s and later
in the decade published a twenty-five
page booklet on the subject (Rowan
1979). The political and scientific
establishments also began to be
drawn into the debate, as indicated by
some selected events (Table 3). The
first major political initiative on alter-
natives came in 1971 when the Coun-
cil of Europe passed Resolution 621.
This proposed, among other things,
the establishment of a documenta-
tion and information center on alter-
natives and tissue banks for research.
Deliberations on Resolution 621 did
not begin until the late ’70s, and the
ensuing final Council of Europe Con-
vention dropped some of the specific
recommendations on alternatives.
Instead, the Convention reflected the
broad concern over animal research
and made some rather general rec-
ommendations on alternatives.
In Europe a number of countries
(for example, Denmark, the Federal
Republic of Germany, the Netherlands,
Sweden, and Switzerland) enacted ani-
mal research legislation that included
specific support for alternatives. In
Sweden the government established
an advisory Central Committee on
Experimental Animals to develop and
promote alternatives and allocated
the equivalent of $90,000 annually
for the support of research on alter-
natives. This represented the first
government funding for alternatives.
In 1977 the Netherlands Animal Pro-
tection Law included a specific sec-
tion on alternatives that has grown
into a program in which the govern-
ment provides the equivalent of hun-
dreds of thousands of dollars to sup-
port alternatives research.
In the United Kingdom, FRAME
began publishing ATLA Abstracts to
identify articles in the scientific liter-
ature that focused on alternatives.
While the journal had little impact
when it was simply publishing
abstracts, it started to include review
articles in 1976 and then, early in the
’80s, dropped the abstracts altogeth-
er and adopted its current format,
which is centered on original articles.
ATLA (Alternatives to Laboratory
Animals) is now well enough estab-
lished to be covered by the Science
Citation Index.
In the United States, interest in
alternatives grew slowly. By the 
mid-’70s, the term had entered the
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Table 3
Alternatives Chronology: 1970–1979
1970 FRAME publishes Is the Laboratory Obsolete?, 
which outlines replacement methodologies such as
computer modeling, tissue culture studies, and the
use of lower organisms.
1971 Council of Europe Resolution 621 suggests that 
an alternatives database be established, the first
significant government recommendation 
on alternatives.
Bruce Ames of the University of California at Berkeley
introduces a nonanimal test for detecting mutation-
causing substances, later known as the Ames Test,
using a bacterium.
1972 The Felix Wankel Prize (now 50,000 deutsche marks)
for advancing the field of alternatives is offered for
the first time.
1973 FRAME begins to publish ATLA (Alternatives to
Laboratory Animals).
1975 The U.S. National Academy of Sciences holds the
United States’ first major scientific meeting 
on alternatives.
1977 The Netherlands Animal Protection Law includes a
specific section on alternatives that has grown into 
a program in which the government provides the
equivalent of hundreds of thousands of dollars to
support alternatives research.
1978 FRAME hosts “Alternatives in Drug Development 
and Testing” at the Royal Society—Europe’s first 
big scientific meeting on alternatives.
David Smyth, president of the United Kingdom
Research Defense Society—established to support
animal research—publishes the first book examining
alternatives since the publication of Russell and
Burch’s 1959 work.
1979 At the urging of United Action for Animals, the
Research Modernization Act (H.R. 4805), which
would redirect 30–50 percent of animal research
funding to alternatives, is introduced in Congress.
The Swedish government allocates $90,000 in
funding for alternatives—the first government 
funding for alternatives.
The Dutch Minister of Health states that the
government supports the use of alternatives.
126 The State of the Animals: 2001
Table 4
Alternatives Chronology: 1980–1989
1980 American activist Henry Spira launches the Draize
campaign against the rabbit-based eye irritancy test.
As a result of the Draize campaign, Revlon gives a
$750,000 grant to Rockefeller University to establish
an alternatives research program.
The New England Antivivisection Society gives
$100,000 for alternatives research on tissue culture,
and a second animal-welfare consortium provides
$176,000 for Chorio-Allantoic Membrane (CAM) 
test development.
1981 As a result of the Draize campaign, the cosmetics
industry gives $1 million to Johns Hopkins University
to establish the Center for Alternatives to Animal
Testing (CAAT) (Avon and Bristol-Myers Squibb 
were the leading donors).
Swiss animal legislation specifically requires
consideration of alternatives.
Zbinden and Flury-Roversi publish a critique of 
the LD50 Test.
1982 Colgate Palmolive provides $300,000 to investigate
the CAM system.
CAAT holds its first symposium.
1983 Switzerland provides two million Swiss francs over
two years for alternatives research.
The Food and Drug Administration (FDA) formally
announces that it no longer requires data from the
classical LD50 Test.
Utrecht University in the Netherlands establishes
research and education programs directed towards
further implementation of the Three Rs.
1984 FRAME receives £160,000 from the Home Office—the
first UK government funding for alternatives research.
1985 The Health Research Extension Act is passed,
requiring the NIH to develop a plan for alternatives.
Animal Welfare Act amendments are passed,
requiring greater attention to alternatives to research
techniques that cause pain and distress.
Index Medicus, an index of published biomedical
studies, adds the subject heading “Alternatives 
to Animal Testing.”
The European Research Group into Alternatives 
to Toxicity Testing (ERGATT) is formed.
The Soap and Detergent Association (USA) initiates
the In Vitro Alternatives Program.
1986 CAAT and Bausch and Lomb sponsor a workshop 
on alternatives and acute ocular irritation testing.
The UK’s Animals (Scientific Procedures) Act
replaces the 1876 act.
The U.S. Congress’s Office of Technology Assessment
issues a landmark report, “Alternatives to Animal Use
in Research, Testing and Education.”
The Council of Environmental Ministers of the
European Community enacts EC Directive 86/609,
requiring that member countries develop legislation
promoting the Three Rs.
An FDA survey reports a 96 percent decrease in the
use of the classic LD50 tests in 1985 compared with
the period 1975–1979.
Two new cell toxicology journals, Toxicology In Vitro
and Molecular Toxicology, are established.
The Organization for Economic Cooperation and
Development (OECD) announces changes in its
guidelines for acute oral and dermal toxicity and
starts to discuss alternatives.
British Industrial Biological Research Association
(BIBRA) increases funding of alternatives research 
to £700,000 per annum.
The Industrial In Vitro Toxicology Society (IVTS) 
is established in the United Kingdom.
Federal Republic of Germany enacts new laws 
on animal protection requiring consideration 
of alternatives in animal research.
1987 The HSUS publishes an analysis of the historical
importance of alternative methods in biomedical
research awarded Nobel Prizes.
The Dutch Alternatives to Animal Experiments Platform
is established with participation from government,
industry, and animal welfare organizations.
In Vitro Toxicology: A Journal of Molecular and
Cellular Toxicology is established.
The Swiss Foundation “Finanzpool 3 R” is established
to support alternatives research with one million
Swiss francs.
(continued on next page)
vocabulary of the animal movement
on a large scale and had begun to find
its way into the scientific literature
(Phillips and Sechzer 1989). The
National Academy of Sciences (NAS)
organized a meeting on alternatives in
1975 (NAS 1977), but the broader sci-
entific community was not happy
about the idea of alternatives, and
there was much criticism of the Acad-
emy for providing a platform for “anti-
vivisectionists” by organizing the
meeting. In the late ’70s, Seiling of
United Action for Animals managed to
persuade a New York congressman to
introduce the Research Moderniza-
tion Act, which called on the National
Institutes of Health (NIH) to reallo-
cate 30 to 50 percent of all money
spent on animal research to “alterna-
tives” (in the narrow sense of replace-
ment, not the full Three Rs). The Act
caught the imagination of the animal
protection movement in spite of its
vague language and lack of contact
with political realities. This public
pressure then forced Congress to start






The growing pressure from the ani-
mal protection community for alter-
natives paid dividends in the ’80s, 
as industry in Europe and America
began to embrace the alternatives
concept and governments played an
increasingly important role (Table 4).
In 1983 Switzerland enacted a leg-
islative requirement for consideration
of alternatives and the government
earmarked two million Swiss francs
over two years for alternatives
research. Five years later the Swiss
government established an office for
animal experiments and alternatives.
In 1986 the Council of Environmen-
tal Ministers of the European Com-
munities passed EEC Directive 86/
609, which required member coun-
tries to develop enabling legislation
promoting the Three Rs. The Animals
(Scientific Procedures) Act of 1986,
replacing the 1876 Cruelty to Ani-
mals Act, was passed in the United
Kingdom. It required greater atten-
tion to the issue of animal suffering
(refinement). Also in 1986 the Feder-
al Republic of Germany enacted new
laws on animal protection requiring
consideration of alternatives in 
animal research. Three years later
Germany established the Center for
the Documentation and Evaluation 
of Alternative Methods to Animal
Experiments, known by its Ger-
man acronym ZEBET, which spear-
headed several government initiatives
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continued from previous page
Table 4
Alternatives Chronology: 1980–1989
1988 A government/industry workshop is held on
alternatives in ocular irritancy testing, to review 
the Soap and Detergent Association’s Alternatives
Program.
The Industrial In Vitro Toxicology Group holds 
its first meeting.
The U.S. Republican presidential platform encourages
the implementation of alternatives to animal testing.
The J.F. Morgan Foundation for Alternatives Research
is established in Canada.
The Swiss government’s Office for Animal
Experiments and Alternatives is established.
1989 The Center for the Documentation and Evaluation of
Alternative Methods to Animal Experiments, known
by its German acronym ZEBET, is established 
in Germany.
Procter and Gamble announces that it is contributing
$450,000 per year for three years to its University
Animal Alternative Research Program.
Avon Products announces that it will no longer use
the Draize Test.
The Scandinavian Society for Cell Biology establishes
the Multicenter Evaluation of In Vitro Cytotoxicity
(MEIC) to assess alternatives to LD50 testing for
acute toxicity.
The Second International Conference on Practical 
In Vitro Toxicology is held in the United Kingdom.
The Swedish Fund for Scientific Research without
Animal Experiments invests 700,000 Swedish crowns
in alternatives projects.
The Clonetics Corporation begins to market cells 
and cell testing methods.
The American Anti-Vivisection Society establishes 
the Demeter Fund (later known as the Alternatives
Research and Development Foundation) in order to
support nonanimal research, funding up to $50,000
annually for one or more projects.
to validate alternative tests. In the
Netherlands government officials
began collecting data on the extent of
the suffering experienced by laborato-
ry animals, and the Organization for
Economic Cooperation and Develop-
ment (OECD), driven by representa-
tives from Europe, began to address
the Three Rs in their guidelines for
toxicity testing. 
Worldwide, probably the most sig-
nificant event in the ’80s was the
launching of campaigns in many of
the developed countries against ani-
mal testing of cosmetics, toiletries,
and household products. These cam-
paigns built on the efforts and publi-
cations during the late ’70s by scien-
tists and organizations such as
FRAME, which laid out the scientific
challenges to the routine use of ani-
mals in toxicity testing (Balls et al.
1983; Zbinden and Flury-Roversi
1981). The main actor in the U.S. ani-
mal protection campaign was labor
and civil rights activist Henry Spira,
who turned his attention to animals
after reading an article by Australian
philosopher Peter Singer (1973).
Spira contacted with activists in Eng-
land (such as Jean Pink of Animal
Aid, who had been targeting cosmet-
ics testing since 1977), Europe, and
Australia and helped to focus and
coordinate protests against the eye
irritancy testing (the Draize Test) of
cosmetics worldwide.
In the United States, Spira’s cam-
paign built a coalition of four hun-
dred animal protection organizations
that targeted the use of the Draize
Test by cosmetic companies in gener-
al and Revlon in particular. Within
twelve months, the coalition’s activi-
ties resulted in more than $1.75 
million of funding for alternatives
research. The Rockefeller University
received $750,000 from Revlon to
establish a laboratory for in vitro
toxicological assay development, and
the Johns Hopkins University Center
for Alternatives to Animal Testing
(CAAT) was established with $1 mil-
lion from the Cosmetic, Toiletry, and
Fragrance Association. Avon Prod-
ucts, Bristol-Myers Squibb, and other
companies provided the bulk of the
funds for CAAT and also provided
funds for FRAME programs in the
United Kingdom.
The effectiveness of Spira’s cam-
paign was based on several factors.
First, he engaged in extensive prelim-
inary planning and preparation. For
example, Spira acquired numerous
copies of the government Draize Test
training film and slides (showing
inflamed and damaged rabbit eyes)
before the campaign started. (By late
1980 these materials were no longer
being handed out for free by the gov-
ernment to anyone who asked.) Sec-
ond, he did not shy away from the
hard-nosed street politics he had
learned in the labor and civil
rights campaigns; he made skill-
ful use of demonstrations and the
media. Third, he was always willing
to negotiate with the opposition and
he avoided ad hominem attacks and
insults. This earned him the respect
of his opponents. Fourth, he
engaged in a constant search for
solutions in which everyone could
feel he or she had won something.
(Importantly, he did not boast to the
media about victories over corpo-
rate targets.) When Revlon finally
negotiated a settlement with Spira
that set up the Rockefeller alter-
natives research program, Spira not
only stopped his campaign, but he
also praised Revlon for its innovative
program and invited other cosmetic
companies to take similarly pro-
gressive steps.
The Draize campaign initiated
enormous changes in the field of
alternatives in toxicity testing. From
1981 to 1991, there was a tremen-
dous shift in attitude toward alterna-
tives in toxicity testing within indus-
try. Corporate toxicologists who had
gone along with the initial grants for
alternatives research in 1980 and
1981 because they felt such actions
were necessary for public relations
reasons, became excited by the tech-
nical and scientific challenge of alter-
natives by the end of the decade. 
Colgate-Palmolive began to fund
research into the Chorio-Allantoic
Membrane (CAM) test in 1982 (to
the tune of $300,000) and within
three years had set up an alternatives
program in its in-house laboratories.
Procter and Gamble and Bristol-
Myers Squibb made the search for
alternatives part of their corporate
culture; they currently provide mil-
lions of dollars annually for intramur-
al and extramural alternatives pro-
grams. Industrial in vitro toxicology
associations have been started in
both Europe and the United States,
and several toxicology journals spe-
cializing in in vitro approaches were
established in the late 1980s. For-prof-
it companies that develop and market
in vitro tests, such as the Clonetics
Corporation and the National Testing
Corporation, later known as In Vitro
International, were established.
Despite all the interest, however,
scientists were still cautious about
relying too heavily on the new in vitro
techniques. Toxicological risk evalua-
tion is a difficult art, and the trans-
formation of alternative methods
from screening tools for preliminary
decision-making to their use as
replacements for whole animals did
not begin to come to fruition until
the 1990s. However, a widespread
consensus emerged during the ’80s
that toxicology testing needed to
move in a different direction. Thus, at
CAAT’s first symposium (in 1982),
the participants mostly wondered if
an alternative to the Draize Test could
be found (Goldberg 1983), but within
five years, participants at CAAT sym-
posia were discussing when such an
alternative would be available.
While similar developments were
evident in Europe, there were large
segments of scientists outside indus-
try that resisted the concept of alter-
natives in the United States. In fact,
important research institutions such
as the NIH avoided use of the term
“alternatives” whenever possible. For
example, the Health Research Exten-
sion Act of 1985 required the NIH to
establish an alternatives program, to
which the NIH gave the awkward title
“Biomedical Models and Materials
Resources.” A few years later, a Public
Health Service draft document on ani-
mal welfare commented that “efforts
have led to the discovery of research
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methods that are useful as ‘adjuncts’
to animal research, in that they com-
plement animal models but rarely
replace them. Thus, these adjuncts
are not true ‘alternatives’—even the
use of this latter term can be mislead-
ing” (Public Health Service 1989). 
A more balanced approach to the
issue was evident in the U.S. Office of
Technology Assessment’s landmark
report, “Alternatives to Animal Use in
Research, Testing and Education,”
which was produced by a government
office outside the orbit of the NIH and
Public Heath Service. In fact, in draft-
ing the Animal Welfare Act, Congress
stipulated that the U.S. Department
of Agriculture, and not the Public
Health Service or its parent agency
(the Department of Health, Educa-
tion, and Welfare, as it was then








If the 1970s were marked by an
increase in interest in alternatives
and the ’80s by an increase in activity
on this front, the 1990s was a period
of maturation for the alternatives
approach. The field already had a few
academic centers, high-technology
companies, and journals dedicated to
the cause, as well as backing from
national laws. What it needed was a
better sense of when a new alternative
test was qualified to replace an ani-
mal test; in other words, What consti-
tuted adequate “validation” (Gold-
berg 1987)? The field also needed
more government-based centers not
only to partner with industry and oth-
ers in validating alternative tests, but
perhaps more importantly, to give
their stamp of approval to adequately
validated tests, which would then
allow for regulatory acceptance. 
In Europe both needs were
addressed by the establishment in
1992 of the European Centre for
the Validation of Alternative Meth-
ods (ECVAM), headed by Michael
Balls of FRAME (Table 5). ECVAM
took an active role in establishing
validation criteria and in funding
and managing validation programs
for promising alternative methods,
and it was the European Union’s
(EU) primary authority for approv-
ing alternative tests. 
ECVAM’s counterpart in the United
States is the Interagency Coordinating
Committee on the Validation of Alter-
native Methods (ICCVAM), established
in 1994. ICCVAM was the successor to
the informal Interagency Regulatory
Alternatives Group and was an out-
growth of the NIH Revitalization Act of
1993. This legislation directed the
National Institute of Environmental
Health Sciences (NIEHS, one of the
NIH institutes) to establish criteria for
the validation and regulatory accep-
tance of alternative testing and to out-
line a process for regulatory review of
potential alternative methods. To
accomplish these tasks, the NIEHS
asked the various federal regulatory
and research-oriented agencies to
appoint representatives to an ad hoc
interagency committee to draft a
report. The ICCVAM report, “Valida-
tion and Regulatory Acceptance of
Toxicological Test Methods,” was
issued in 1997 (ICCVAM 1997). With
ICCVAM’s original mission accom-
plished, the participating federal agen-
cies decided to change ICCVAM’s sta-
tus from an ad hoc entity to a standing
committee to facilitate the ongoing
regulatory review and acceptance of
alternative methods. ICCVAM is
staffed by employees who have other
responsibilities to their parent agen-
cies, so to facilitate ICCVAM’s new
role, the NIEHS established a support
center, the National Toxicology Pro-
gram Interagency Center for the Eval-
uation of Alternative Toxicological
Methods (NICEATM) in 1998.
Several large-scale validation efforts
were launched during the 1990s, and
ECVAM played a role in many of these
through coordination, participation,
or funding. The establishment of
ECVAM and ICCVAM gave industry
the confidence to invest in new tests
and their validation, knowing that
regulatory authorities were available
to give advice on validation and
acceptance criteria and foster the
administrative process of regulatory
acceptance. The efforts of ECVAM,
ICCVAM, industry, and others began
to bear fruit in the late 1990s. In
1998 ECVAM endorsed the 3T3 Neu-
tral Red Uptake Phototoxicity Test for
assessing phototoxicity and the
Transepithelial Electrical Resistance
Test and Episkin (and similar bioengi-
neered skin constructs) for assessing
skin corrosivity. The same year
ECVAM also endorsed in vitro meth-
ods as alternatives to the ascites
(mouse-based) method for producing
monoclonal antibodies. The following
year, ICCVAM recommended Corrosi-
tex® for assessing skin corrosivity 
and the Local Lymph Node Assay (a
reduction and refinement alterna-
tive) for assessing allergic contact
dermatitis. ICCVAM’s recommenda-
tions are not binding on the individ-
ual regulatory agencies (for example,
the Food and Drug Administration),
but may be accepted (or not) accord-
ing to agency needs; so far the agen-
cies have acted favorably on ICC-
VAM’s recommendations.
In addition to ICCVAM and ECVAM,
the OECD has emerged as a signifi-
cant authority in the acceptance of
alternative methods. The OECD, an
international organization that facili-
tates trade, formally accepted the
Fixed Dose Procedure (in 1991), the
Acute Toxic Class Method (1993),
and the Up and Down Method (1997)
as reduction alternatives to the LD50
Test for acute toxicity (the Fixed Dose
Procedure is also a refinement alter-
native). In 1996 the OECD hosted a
workshop to develop internationally
harmonized criteria for the validation
and regulatory acceptance of alterna-
tive methods (OECD 1996).
The “internationalization” of the
alternatives field has also been aided
by the establishment of the triennial
World Congress on Alternatives and
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Table 5
Alternatives Chronology: 1990–1999
1990 CAAT and ERGATT hold a workshop on validation 
of alternative methods.
The University of California Alternatives Center 
is established at UC–Davis.
The Platform for Alternatives to Animal Experiments
in the Netherlands allocates the equivalent of
$700,000 annually for the promotion and validation
of research into the Three Rs and the improvement 
of housing and care systems.
The HSUS establishes the Russell and Burch Award
for scientists who have made outstanding
contributions to alternative methods.
The Japanese Society for Alternatives to Animal
Experimentation begins publishing the journal
AATEX (Alternatives to Animal Testing and
Experimentation).
1991 The Interagency Regulatory Alternatives Group holds a
workshop, “Eye Irritation Testing Alternatives: Proposals
for Regulatory Consensus,” in Washington, D.C.
The HSUS presents Alan Goldberg, director of CAAT,
with the first Russell and Burch Award.
The OECD accepts the Fixed Dose Procedure as an
alternative to the LD50 Test.
Representatives of regulatory agencies in Japan,
Europe, and the United States agree to drop the
classic LD50 Test as a required measure of 
acute toxicity.
The UK Home Office announces a grant program for
the funding of alternatives research.
The Second Report of the FRAME Toxicity Committee
is published in ATLA.
The Swiss Institute for Alternatives to Animal Testing
(SIAT) is established in Zurich.
1992 The European Centre for the Validation of Alternative
Methods (ECVAM) is established.
The European Parliament amends the Cosmetic
Directive 76/768 to ban the marketing of cosmetics
tested on animals after January 1, 1998 (a decision
on the ban is later postponed until June 30, 2000).
CAAT hosts a tenth anniversary conference in
Baltimore, Md., giving Founders’ Awards to Dr. D.A.
Henderson, the CTFA, and Henry Spira.
1993 The NIH Revitalization Act of 1993 directs the NIEHS
to establish criteria for the validation and regulatory
acceptance of alternative testing and to outline a
process for regulatory review of potential alternative
methods; it also directs the NIH director to establish
an alternatives program and to report on its 
progress annually.
The first World Congress on Alternatives and Animal
Use in the Life Sciences: Education, Research, and
Testing, takes place in Baltimore.
Member states of the European Union agree on the
goal that everything possible should be done to
achieve a reduction of 50 percent in the use of
vertebrate animals for experimentation and other
scientific purposes by the year 2000.
The Interagency Regulatory Alternatives Group holds
its second meeting on alternatives, in Washington, D.C.
Dr. Michael Balls of FRAME is appointed director 
of ECVAM.
1994 The U.S. federal government establishes the
Interagency Coordinating Committee on the
Validation of Alternative Methods (ICCVAM), 
co-chaired by William Stokes of NIEHS and 
Richard Hill of EPA, in response to the 
1993 NIH Revitalization Act.
The Netherlands Centre for Alternatives to Animal
Use (NCA) is established as a national information
center on alternatives.
1995 The Gillette Company and The HSUS launch a
program to fund research and development of
alternative methods; two grants of $50,000 each 
are awarded annually.
1996 The second World Congress on Alternatives and
Animal Use in the Life Sciences is held in Utrecht,
the Netherlands.
The OECD holds a workshop to develop
internationally harmonized criteria on validation 
and regulatory acceptance.
CAAT, The HSUS, Procter and Gamble, and other
organizations establish Altweb, a website devoted 
to information on alternative methods.
1997 ICCVAM issues guidelines on criteria for validation
and regulatory acceptance of alternative methods.
The Institute for In Vitro Sciences is established 
in Gaithersburg, Md.
(continued on next page)
Animal Use in the Life Sciences, the
first of which was held in Baltimore in
1993 (Goldberg and van Zutphen
1995); the second in Utrecht, the
Netherlands, in 1996 (van Zutphen
and Balls 1997); and the third in
Bologna, Italy, in 1999. The interna-
tional exchange of information on
alternatives was also given a boost 
in 1996 with the establishment of
Altweb, an Internet web site spear-
headed by CAAT, Procter and Gamble,
The HSUS, and others. 
Political pressure played a signifi-
cant role in moving the alternatives
issue during the 1990s, more directly
in Europe than in the United States.
The issue had some momentum of its
own, but outside pressure spurred
progress. In Europe, for example, the
European Parliament amended the
Cosmetic Directive 76/768 to ban
the marketing of cosmetics tested 
on animals after January 1, 1998,
regardless of whether such testing
was conducted in Europe. Although a
decision on the marketing ban was
later postponed until June 30, 2000,
the Cosmetic Directive amendment
led to the formation of ECVAM and
encouraged research and development
of alternatives by the European cos-
metics trade association (COLIPA)
and others. The marketing ban would
have affected companies in the Unit-
ed States as well as in Europe, so the
amendment also kept some political
pressure focused on the issue in the
United States. 
Since the most recent postpone-
ment of the marketing ban, a new
amendment (the seventh) has been
proposed. It calls for: (1) a ban on
animal testing of finished products in
the European Union as soon as the
directive comes into force, (2) a ban
on animal testing of cosmetic ingre-
dients where alternatives are avail-
able, and (3) a complete ban on ani-
mal testing of cosmetic ingredients
within three years of implementation
of the directive, regardless of the
availability of alternatives. The
European Commission has stated that
only one two-year postponement of
the ingredients-testing ban would be
considered. Consequently, an absolute
ban on ingredients testing could
become effective within five years of
implementation of the directive.
Finally, the directive states that a
marketing ban, which would have
affected countries outside of the
European Union, will not occur due
to potential problems with World
Trade Organization rules; this effec-
tively “kills” the proposed sixth
amendment.
Alternatives legislation in the Unit-
ed States in the 1990s was largely a
cooperative venture between in-
dustry and animal protection. The
alternatives language in the NIH Revi-
talization Act of 1993, which led to
the creation of ICCVAM, was the
product of efforts of several industry
and animal protection representa-
tives working with Rep. Henry Wax-
man. A similar coalition led to the
introduction of the ICCVAM Autho-
rization Act in the Senate (1999) and
House (2000) in an effort to strength-
en ICCVAM and make it a permanent
entity. As of October 2000, this legis-
lation was pending.
Discussion
Many animal protectionists are frus-
trated with the pace at which the use
of animals in research and testing is
being replaced, reduced, and refined.
However, the growth of the alterna-
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Table 5
Alternatives Chronology: 1990–1999
1998 The HSUS presents the FDA’s Neil Wilcox and
ICCVAM’s William Stokes with the Russell and Burch
award for their contribution to the development 
of alternatives.
ECVAM accepts the following alternative methods: 
3T3 NRU PT test as an alternative for assessing
phototoxicity, Episkin and similar methods for assessing
skin corrosivity, and TER (transepithelial electrical
resistance) test for assessing skin corrosivity.
ECVAM endorses in vitro methods as alternatives 
to the ascites method for the production of 
monoclonal antibodies.
The National Toxicology Program Interagency 
Center for the Evaluation of Alternative Toxicological
Methods (NICEATM) is established to provide 
support to ICCVAM.
1999 The third World Congress on Alternatives and Animal
Use in the Life Sciences is held in Bologna, Italy.
The HSUS presents Procter and Gamble scientist 
Dr. Katherine Stitzel with the Russell and Burch
award for her contribution to the development 
of alternatives.
CAAT holds TestSmart (a humane and efficient
approach to regulatory toxicity data) workshops in
order to discuss alternatives to animal testing in the
Environmental Protection Agency’s High Production
Volume (HPV) chemical testing program.
The EPA announces major changes in its HPV
program, including funding for alternative methods,
following the TestSmart workshops and negotiations
with animal protection organizations.
ICCVAM endorses Corrositex® for the assessment of
skin corrosivity and the Murine Local Lymph Node
Assay for the assessment of allergic contact dermatitis.
tives field since the publication of
Russell and Burch’s seminal book in
1959 has been remarkable, especially
considering that the animal protec-
tion community itself did not
embrace the alternatives issue in a
significant way until the late 1970s.
During the 1980s cosmetics and con-
sumer products companies began
investing millions of dollars into
research and development of alterna-
tives, national governments incorpo-
rated the alternatives approach into
their animal protection legislation
and, in some cases, began funding
research and development of alterna-
tives, some companies began develop-
ing and marketing alternative test
kits, academic centers devoted to the
issue began to be established, and the
field of in vitro toxicology blossomed.
During the 1990s government cen-
ters devoted to the validation and reg-
ulatory acceptance of alternative
methods were established in Europe
and the United States, the triennial
World Congresses on Alternatives
began, and alternative tests began to
be formally approved and accepted by
regulatory agencies. 
Have these developments translat-
ed into a decrease in the use of labo-
ratory animals and in their levels of
pain and distress? Most countries
that keep records on the use of
research animals report a fall in labo-
ratory animal numbers during the
1980s and 1990s, in some cases a dra-
matic fall (Rowan et al. 1995). The
statistics from the United Kingdom
show a decline in annual animal use
from around 5.5 million in 1976 to
2.7 million in 1998. Sir Peter
Medawar, who predicted in 1969 that
such a decline would begin in 1979 or
even earlier (Medawar 1972), was
obviously more far-sighted than the
Littlewood Committee, which report-
ed in 1965 that animal use would not
be influenced by the development of
new (alternative) technology.
However, a key question is this:
How much of the decline in research
animal use in the United Kingdom
and in other countries has resulted
from pressure to develop and use
alternative methods? The available
data is not adequate to provide an
unequivocal answer. While other fac-
tors such as the cost of research ani-
mals and the increased sensitivity and
specificity of new techniques have no
doubt been important, it is also likely
that pressure from animal groups
(and progressive scientists) calling
for the development and use of “alter-
native” techniques has played a role
in reducing animal use. Animal pro-
tectionists certainly increased aware-
ness of the Three Rs and humane
issues within the scientific community.
Technical developments over the
past thirty years have, for example,
reduced the demand for animals in
the production and testing of polio
vaccine and insulin (Hendriksen
1988; Trethewey 1989). Hendriksen
describes how the number of mon-
keys used in the production and test-
ing of polio vaccine in the Nether-
lands was reduced from 4,570 in 1965
to 30 in 1984 by a series of technical
improvements, even though the actu-
al amount of polio vaccine produced
was about the same in the two years.
The technical improvements were the
result of advances in molecular tech-
niques and cell culture biology.
Trethewey describes a similar pro-
cess in insulin testing that reduced
the demand for mice by 95 percent
between 1970 and 1986. The major
technical advance was the introduc-
tion of a mouse blood glucose test in
place of the mouse convulsion test.
This relatively nonstressful assay per-
mitted the re-use of the same mouse
for more than one assay leading to a
further reduction in the number of
animals required. High Pressure Liq-
uid Chromatography (HPLC) tech-
niques have been developed and
introduced, and it is now possible to
standardize insulin preparations using
only a handful of mice to ensure that
each batch is biologically active. A
life-time supply of insulin for one dia-
betic now requires testing on the
equivalent of only a single mouse and
it is possible that mice will be elimi-
nated altogether as further technical
advances are made.
Innovations in toxicity testing and
the standardization of therapeutics
such as insulin have reduced the
demand for animals in some proce-
dures. However, the most significant
reductions have come in the search
for new drugs. As pharmaceutical
companies have switched from animal
to in vitro screens for agents with
potential therapeutic activity, they
have recorded dramatic decreases in
animal use. Hoffman–La Roche, for
example, reduced its annual animal
use from one million to about
300,000 without changing the num-
ber of new drug entities under inves-
tigation (Anonymous 1990). A switch
by the National Cancer Institute from
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a mouse screen for potential anti-
cancer agents to human cancer cell
culture screens has resulted in a sav-
ing of several million mice per year
(Rowan and Andrutis 1990). 
Russell (1995) attributes the devel-
opment of replacement technology,
and the consequent decreases in lab-
oratory animal use, to the waning
influence of what he and Burch
(1959) called the “high fidelity” falla-
cy—that models had to look like the
organism being modeled, no matter
what the power of the model to “dis-
criminate” or elucidate the process
under study. Thus mammals such as
mice, dogs, and primates have histor-
ically been preferred as models of
humans because they have high fideli-
ty to humans, not necessarily because
they have high discrimination. The
high fidelity fallacy has lost its cur-
rency as the power of low fidelity–
high discrimination techniques, such
as tissue culture and use of inverte-
brate species (for example, C. ele-
gans) has been demonstrated. 
The impact of refinements on ani-
mal pain and distress is even harder
to gauge than the impact of replace-
ments and reductions on animal num-
bers. While animal numbers declined
during the 1980s and 1990s, increas-
ing attention was being paid to the
neglected “R”—refinement—thanks
in part to new legislation in Europe
and the United States. In the United
Kingdom, the passage of the 1986
Scientific Procedures (Animals) Act
focused more attention on animal dis-
tress and led to a virtual doubling
(from 21 percent to 36 percent of all
procedures) in the rate of anesthetic
use in animal research in six years
(Anonymous 1990). In the United
States, protocol review by Institution-
al Animal Care and Use Committees
is increasingly focusing on reducing
animal pain and distress.
Two technical advances that will
significantly decrease pain and dis-
tress in laboratory animals are non-
invasive imaging and telemetric
approaches to animal data (Stokstad
1999). These approaches not only
reduce or eliminate pain and distress,
they also allow for a 75 to 80 percent
reduction in animal numbers by
increasing the reliability of the data
and improving experimental design.
One of the major challenges in
making further progress in alterna-
tive methods is the indifference, if
not the antagonism, to the alterna-
tives approach on the part of many
academic researchers worldwide.
While the NIH no longer automati-
cally characterizes alternatives as
mere “adjuncts” of animal research,
and the NIEHS actively promotes
alternative methods, some biomed-
ical research advocates have argued
that use of the term “alternatives”
implies that one needs to apologize
for using animals in research and
that this gives the public the wrong
impression (Goodwin 1992). While
such hostility to the alternatives
approach is abating, the field of alter-
natives would progress much faster if
academic researchers were more
sympathetic to the approach. 
Another challenge in implementing
alternatives and in decreasing animal
use is the growth of genetic engineer-
ing, particularly in mice. The NIH’s
in-house use of mice reached a low of
about 300,000 in 1991 but has more
than doubled since then, according to
NIH Annual Reports and NIH Reports
to the USDA. Genetic engineering
can sometimes be harnessed to
reduce (and refine) animal use (Gor-
don 1991). It can also be argued that
the increasing numbers of genetically
engineered mice are at least some-
what offset by a corresponding
decrease in the use of other mice or
species, thereby nullifying any
increase in overall numbers. This
seems to be what is happening in the
United Kingdom, where the use of
genetically modified mice has gone
up tenfold, to around 500,000, but
total mouse use has fallen slightly. At
the very least, the impact of genetic
engineering on animal use should be
carefully monitored, given its poten-
tial to reverse the decreases in animal
use seen during the 1980s and 1990s.
Conclusion
The program that UFAW set in motion
in 1954 has born significant fruit.
Although Major Hume would no
doubt be surprised at the scope and
potential of biomedical science today,
he would be pleased at the growing
recognition accorded to Russell and
Burch (1959). The number of cita-
tions to Russell and Burch’s book in
the scientific literature increased
dramatically during the 1980s and,
especially, the 1990s (Figure 1).
In 1959 Hume spoke to an Ani-
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mal Care Panel meeting in Washing-
ton, D.C.:
A more recent event has been the
publication of a remarkable book
by Russell and Burch entitled The
Principles of Humane Experimen-
tal Technique. This deserves to
become a classic for all time, and
we have great hopes that it will
inaugurate a new field of system-
atic study. We hope that others
will follow up the lead it has given,
and that a generalized study of
humane technique, as a systemat-
ic component of the methodology
of research, will come to be con-
sidered essential to the training
of a biologist (Hume 1962).
This has indeed come to pass in the
Netherlands and other parts of
Europe (van Zutphen, Baumans, and
Beynen 1993), and we are hopeful
that the Three Rs will become fully
incorporated into the training of biol-
ogists in the United States.
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